Epilepsy Monitoring Device Market size is expected to grow USD 96.6 billion by 2030

The Market Statsville Group (MSG) publishes the new report on the "Epilepsy Monitoring Device Market by Product (Conventional Devices and Wearable Devices (Deep Brain Stimulation Devices and Monitoring Devices)), by End-Users (Clinics, Hospitals, Home Care Settings, and Other End Users), by Region - Global Share and Forecast to 2030". The global epilepsy monitoring device market size is expected to grow from USD 61.5 billion in 2021 to USD 96.6 billion by 2030, at a CAGR of 6.6% during the forecast period. Epilepsy monitoring device is used to diagnose brain abnormities through different devices as real-time epilepsy monitoring and seizure detection have become important over the past decades. According to the centers for disease control and prevention, about 3.4 million Americans, including 470,000 children, live with epilepsy. On the other hand, according to the National Health Institute, about 35 % don't respond to medication to control seizures. Thereby, many devices have been launched in the last decades, such as mHealth wearable SmartWatch Inspyre™ for the Apple Watch. mHealth wearable is used for tracking epileptic seizures and alerts the care teams. This improves the safety of the patient.

Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/epilepsy-monitoring-device-market

Epilepsy is one of the common neurological diseases worldwide. Rising cases of epilepsy worldwide is the major driving factor for the epilepsy monitoring device market. The number of patients who have epilepsy is approximately 50 million cases globally. Such a huge prevalence of the disease creates a major burden in seizure-related disability, stigma, mortality, comorbidities, and costs, increasing the demand for epilepsy monitoring devices.

Global Epilepsy Monitoring Device Market Segmentation
The overall epilepsy monitoring device market has been segmented into the product, end-use, and region.

By Product Outlook (Sales, USD Billion, 2017-2030)

Conventional Devices
Wearable Devices
Deep Brain Stimulation Devices
Monitoring Devices
EEG Devices
Standard EEG
Video EEG
Others/Ambulatory EEG
EMG Devices
MEG Devices
Other Monitoring Devices
By End-Users Outlook (Sales, USD Billion, 2017-2030)

Clinics
Hospitals
Home Care Settings
Other End Users
By Region Outlook (Sales, USD Billion, 2017-2030)

Direct Purchase Report: https://www.marketstatsville.com/buy-now/epilepsy-monitoring-device-market?opt=2950

North America (US, Canada, Mexico)
South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)
Hospital, by end-users, is estimated to hold the largest market share during the forecast period

Based on end-users, global epilepsy monitoring device market is classified into clinics, hospitals, home care settings, and other end users. Among these, the hospital's segment accounted for the largest market share of 45.3%. Hospitals are anticipated to hold the maximum revenue share in the epilepsy monitoring devices market owing to increasing availability in emerging markets. The increasing admissions of patients suffering from traumatic brain injuries, epilepsy, and other neurological disorders are the factors driving the segment growth. Hospitals are the primary end-users of epilepsy monitoring devices as it diagnoses brain abnormalities and evaluate the results in detail for clinical and research purposes. Therefore, the hospital segment is dominating the market due to the high patient turnaround and frequent readmissions.

Access full Report Description, TOC, Table of Figure, Chart, etc: https://www.marketstatsville.com/table-of-content/epilepsy-monitoring-device-market

North America accounts for the largest market share in epilepsy monitoring device market 2021

Based on the regions, the global epilepsy monitoring device market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. North America led the market in the global Epilepsy Monitoring Devices Market in 2021, followed by Europe and the Asia Pacific. The North America region was the largest revenue contributor in 2021, and captured 37.5% of the market share. The growing prevalence of epilepsy, increasing funding initiatives, and large presence of device manufacturing companies in the U.S. will contribute to the largest revenue shares in the region.

The Rotterdam Study also determined that a history of stroke or risk factors for stroke were associated with an increased lifetime risk for epilepsy. As per the American Heart Association projections, an additional 3.4 million U.S. adults 18 and older will have had a stroke by 2030. Additionally, 80% of Canadians have at least one of the risk factors for heart and cerebrovascular disease, which increases the risk of epilepsy in the North America region. This will also boost the demand for epilepsy monitoring devices for accurate diagnosis and treatment of epilepsy in the region.

Browse complete report: https://www.marketstatsville.com/epilepsy-monitoring-device-market

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the epilepsy monitoring device market. It also consists of the profiles of leading companies such as Natus Medical Incorporated, Nihon Kohden Corporation, LivaNova, PLC, St. Jude Medical, Inc., Empatica Inc., Medtronic plc, Koninklijke Philips N.V., and Boston Scientific Corporation. These market players have focused on acquisitions and expansion to gain a larger market share in the epilepsy monitoring device market.

Related Reports-

Lysosomal Storage Disease Treatment Market - https://www.marketstatsville.com/lysosomal-storage-disease-treatment-market

Novel Vaccine Delivery System Market - https://www.marketstatsville.com/novel-vaccine-delivery-system-market

Contact US:
Eric Martin
800 Third Avenue Suite A #1519
New York, NY 10022
+1 (646) 663-5829 | India: +91-702-496-8807
Email: sales@marketstatsville.com
MSG Blog https://marketstatsvilleblogs.com/
Web: https://marketstatsville.com/

About US:
Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG initiated its work in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services.
We the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact.

This release was published on openPR.